Profit Margin (Quarterly)

Profit Margin: Net Income as a portion of total sales revenue. Calculated as: Net Income / Total Revenues

Alamar Biosciences, Inc. (ALMR) had Profit Margin of -81.91% for the most recently reported fiscal quarter, ending 2026-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2026-03-31

Income Statement Financials
Revenue	26.04M
Net Income	-21.32M
Cost of Goods Sold	11.58M
Gross Profit	14.46M
Operating Expenses	38.38M
Operating Income	-12.35M
Non-Operating Income/Expense	-8.51M
Pre-Tax Income	-20.86M
Normalized Pre-Tax Income	-20.86M
Income after Taxes	-21.32M
Income from Continuous Operations	-21.32M
Consolidated Net Income/Loss	-21.32M
Normalized Income after Taxes	-21.32M
EBIT	-12.35M
EBITDA	-11.11M
Weighted-Average Shares Outstanding (Basic)	12.26M
Weighted-Average Shares Outstanding (Diluted)	12.26M
Earnings per Share (EPS) (Basic)	-1.74
Earnings per Share (EPS) (Diluted)	-1.74
Balance Sheet Financials
Current Assets	141.47M
Property, Plant, and Equipment	10.47M
Long-Term Assets	44.98M
Total Assets	186.45M
Current Liabilities	24.05M
Long-Term Debt	74.97M
Long-Term Liabilities	105.48M
Total Liabilities	129.53M
Common Equity	-178.07M
Tangible Shareholders Equity	55.09M
Shareholders Equity	56.92M
Common Shares Outstanding	12.87M
Cash Flow Statement Financials
Cash Flow from Operating Activities	-20.35M
Cash Flow from Investing Activities	-0.78M
Cash Flow from Financial Activities	55.76M
Beginning Cash	34.91M
End Cash	69.49M
Increase/Decrease in Cash	34.58M
Stock-Based Compensation	1.47M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.88
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.57
Debt to Equity Ratio	1.32
Gross Margin	55.53%
Operating Margin	-47.42%
EBIT Margin	-47.42%
EBITDA Margin	--
Pre-Tax Profit Margin	-80.13%
Profit Margin	-81.91%
Free Cash Flow	-20.95M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.14
Inventory Turnover	0.29
Receiveable Turnover	1.33
Days Sales in Receivables	67.49
Return on Equity	11.98%
Return on Tangible Equity	-38.71%
Return on Assets	-11.44%
Return on Investments	-16.17%
Book Value Per Share	4.42
Free Cash Flow per Share	-1.71
Operating Cash Flow per Share	-1.66

Data from Zacks Investment Research, Inc.